Characterization of protein aggregation: The case of a therapeutic immunoglobulin

被引:79
作者
Demeule, Barthelemy
Lawrence, M. Jayne
Drake, Alex F.
Gurny, Robert
Arvinte, Tudor
机构
[1] Univ Geneva, Sch Pharmaceut Sci, Dept Pharmaceut & Biopharmaceut, Univ Lausanne, CH-1211 Geneva 4, Switzerland
[2] Kings Coll London, Dept Pharm, London SE1 9NH, England
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS | 2007年 / 1774卷 / 01期
关键词
immunoglobulin; aggregation; characterization; biopharmaceutical; conformation;
D O I
10.1016/j.bbapap.2006.10.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this paper, a therapeutic immunoglobulin (Antibody A) has been characterized in two solutions: (1) 0.1% acetic acid containing 50 mM magnesium chloride, a solution in which the immunoglobulin is stable, and (2) 10 mM sodium phosphate buffer pH similar to 7. The protein solutions were characterized by microscopy, asymmetrical flow field-flow fractionation (FFF), light scattering, circular dichroism, fluorescence and fluorescence lifetime spectroscopy. The results show that Antibody A dissolved in 0.1% acetic acid containing 50 mM magnesium chloride exists as 88% monomer, 2% low molecular weight aggregates and 10% high molecular weight aggregates (> 1 million Dalton). In phosphate buffer, Antibody A formed micrometre-sized aggregates that were best characterized by fluorescence microscopy. The aggregation of Antibody A in phosphate buffer was shown to be concomitant with conformational changes in amino acid residue side chains. The aggregates formed in phosphate buffer were easily disrupted during FFF analysis, indicating that they are formed by weak interactions. The combination of microscopy, asymmetrical flow field-flow fractionation (FFF) and spectroscopy allowed a reliable assessment of protein self association and aggregation. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:146 / 153
页数:8
相关论文
共 18 条
[1]  
[Anonymous], 1999, PRINCIPLES FLUORESCE
[2]   The multi-mode polarization modulation spectrometer: part 1: simultaneous detection of absorption, turbidity, and optical activity [J].
Arvinte, T ;
Bui, TTT ;
Dahab, AA ;
Demeule, B ;
Drake, AF ;
Elhag, D ;
King, P .
ANALYTICAL BIOCHEMISTRY, 2004, 332 (01) :46-57
[3]  
Arvinte T, 2005, BIOTECH PHARM ASPECT, P661
[4]   Determination of second virial coefficient of proteins using a dual-detector cell for simultaneous measurement of scattered light intensity and concentration in SEC-HPLC [J].
Bajaj, H ;
Sharma, VK ;
Kalonia, DS .
BIOPHYSICAL JOURNAL, 2004, 87 (06) :4048-4055
[5]   Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha (IFN-alpha) in normal and transgenic mice [J].
Braun, A ;
Kwee, L ;
Labow, MA ;
Alsenz, J .
PHARMACEUTICAL RESEARCH, 1997, 14 (10) :1472-1478
[6]   Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases [J].
Bucciantini, M ;
Giannoni, E ;
Chiti, F ;
Baroni, F ;
Formigli, L ;
Zurdo, JS ;
Taddei, N ;
Ramponi, G ;
Dobson, CM ;
Stefani, M .
NATURE, 2002, 416 (6880) :507-511
[7]  
Cantor C. R., 1980, BIOPHYS CHEM 2
[8]  
Carpenter JF, 1999, METHOD ENZYMOL, V309, P236
[9]   Comparison of free solution capillary electrophoresis and size exclusion chromatography for quantitating non-covalent aggregation of an acylated peptide [J].
Clodfelter, DK ;
Nussbaum, MA ;
Reilly, J .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1999, 19 (05) :763-775
[10]  
Colón W, 1999, METHOD ENZYMOL, V309, P605